Premium
Association of estrogen receptor‐alpha gene polymorphisms with stroke risk in patients with metabolic syndrome
Author(s) -
Lazaros L.,
Markoula S.,
Xita N.,
Giannopoulos S.,
Gogou P.,
Lagos G.,
Kyritsis A. P.,
Georgiou I.
Publication year - 2008
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.2007.00926.x
Subject(s) - estrogen receptor alpha , stroke (engine) , medicine , estrogen , genotype , estrogen receptor , endocrinology , polymorphism (computer science) , disease , estrogen receptor beta , alpha (finance) , metabolic syndrome , biology , gene , genetics , breast cancer , cancer , obesity , surgery , construct validity , patient satisfaction , mechanical engineering , engineering
Objective – The vascular protective effects of estrogens are mediated by their binding to the two known estrogen receptors. In this study, we examine the association of stroke with two common polymorphisms of the ESR1 gene in patients with metabolic syndrome. Materials and methods – DNA from 130 patients hospitalized for ischemic stroke and 240 healthy controls were genotyped for ESR1 Pvu II and Xba I polymorphisms. Results – Comparing female and male patients, it was found that CCGG diplotype is more frequent in male patients ( P = 0.03). In addition, the AA genotype is associated with the onset of stroke at a younger age in the male patient group ( P < 0.05). Conclusions – These findings suggest that Pvu II and Xba I polymorphisms may affect the age at onset of the first stroke and the probability of developing cerebrovascular disease.